Order Stylage® M Bi-Soft for Clinics

Stylage® M Bi-Soft is a sterile cross-linked hyaluronic acid dermal filler supplied in a ready-to-use 1 mL prefilled syringe for professional injection. Licensed clinics, med spas, and healthcare professionals can order Stylage M Bi-Soft for aesthetic protocols that require controlled gel placement, documented lot tracking, and treatment-room-ready sterile presentation.

This hyaluronic acid filler Stylage M presentation contains cross-linked HA at 20 mg/mL with mannitol and is designed for qualified injectors using established intradermal or subdermal technique. Med Wholesale Supplies serves professional accounts with brand-name aesthetic products sourced through vetted distributors and verified supply channels for licensed clinics.

Price, Pack Details, and Clinic Ordering

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account.

Each unit contains one 1 mL prefilled syringe and two sterile, disposable needles. The outer packaging displays the product identity, lot number, and expiration date for intake records. Your receiving team should reconcile carton details against the packing documentation before the product enters treatment inventory.

Once approved, your team can place orders online and use tracked US delivery with temperature-controlled handling when required to coordinate replenishment around clinic schedules.

What Stylage® M Bi-Soft Is Used For

Stylage® M Bi-Soft is selected in aesthetic practices for moderate contour refinement and wrinkle-softening tasks when a balanced, mid-viscosity HA gel fits the treatment plan. Common professional-use areas include nasolabial folds, marionette lines, subtle chin or jawline refinement, and perioral border definition when appropriate for the individual assessment.

The filler is intended for administration by trained professionals who understand facial anatomy, injection depth, aseptic preparation, and complication management. As with any dermal filler, suitability depends on patient assessment, medical history, product labeling, local protocols, and injector training.

For broader product positioning within the same manufacturer line, clinics can browse the Stylage brand category or use the Stylage dermal filler range discussion to support internal product selection conversations.

How the HA Gel and Bi-Soft Syringe Support Injection Workflows

Stylage® M Bi-Soft uses a cross-linked hyaluronic acid gel network designed to balance cohesivity and elasticity. In practical terms, that rheology helps the gel maintain form under movement while allowing smooth extrusion through compatible needles during controlled placement.

The Bi-Soft syringe platform is designed for ergonomic handling and steady plunger control. Consistent push force can support careful placement in dynamic facial zones, especially when injectors need small adjustments during mid-depth work. Technique, anatomy, tissue quality, and treatment sequencing remain central to the final clinical result.

Mannitol is included as an antioxidant excipient. In dermal filler formulations, antioxidants may help limit free-radical activity associated with injection-related tissue passage. This should not be interpreted as eliminating expected injection-site reactions, which can still occur after HA filler procedures.

For clinics refreshing staff education on HA materials, the article on hyaluronic acid in aesthetic medicine may help frame the product class without replacing formal injector training.

Composition, Ingredients, and Lidocaine Distinction

The active component is highly cross-linked hyaluronic acid at 20 mg/mL. The formulation also includes mannitol, a polyol used in the Stylage line for antioxidant support. This specific presentation does not list lidocaine in the supplied product information.

Clinics that prefer an anesthetic-containing presentation can evaluate Stylage® M Bi-Soft with Lidocaine, subject to clinic protocol and product suitability. The lidocaine distinction matters for consent language, allergy screening, comfort planning, and procedure documentation.

Practices that stock multiple Stylage formats should separate non-lidocaine and lidocaine units clearly during receiving and room setup. Clear labeling reduces pull errors and helps injectors match the product to the documented treatment plan.

Placement Fit and Related Stylage Options

Stylage M is generally positioned as a mid-range HA filler in the Stylage portfolio. It can fit procedures requiring more structure than very light superficial work, while remaining distinct from higher-volume or more robust formulations chosen for deeper contouring.

Stylage L presentations may be considered when protocols call for a different gel profile or treatment objective. Clinics comparing nearby options can review Stylage® L Bi-Soft with Lidocaine or Stylage® L Bi-Soft as part of injector-led portfolio planning.

For finer corrections or lighter placement needs, teams may also assess Stylage® S Bi-Soft. Product choice should reflect treatment area, target tissue plane, desired projection, patient history, and the injector’s familiarity with the gel.

Clinics evaluating brand differences can use Stylage and Juvéderm comparison content for high-level discussion, while final selection should follow approved product information and professional judgment.

Safety, Contraindications, and Professional Precautions

Dermal filler procedures require careful screening and aseptic technique. Common short-term reactions may include injection-site redness, swelling, bruising, tenderness, firmness, itching, discoloration, or mild discomfort. These effects are usually procedure-related but should be documented and monitored according to clinic policy.

Serious complications can occur with soft tissue fillers, including infection, nodules, inflammatory reactions, vascular compromise, tissue necrosis, and visual disturbances if material enters or compresses a blood vessel. Injectors should understand facial vascular anatomy, use appropriate technique, and maintain an emergency protocol for suspected vascular events.

Screening should address prior filler reactions, allergies, active skin infection near the treatment area, immune or inflammatory conditions, pregnancy or breastfeeding status when relevant to local policy, and medicines or supplements that may increase bruising risk. Product use should be deferred when clinical assessment or labeling indicates that treatment is not appropriate.

Clinics should provide clear post-procedure instructions and ensure staff know when escalation is required. Severe pain, blanching, mottled skin, progressive swelling, signs of infection, or visual symptoms warrant urgent professional evaluation.

Storage, Receiving, and Inventory Control

On receipt, inspect the carton for product identity, package integrity, lot number, and expiration date. Do not place compromised, opened, or questionable sterile units into treatment inventory. Maintain receiving records in the format your clinic uses for professional aesthetic products.

Store the product according to the manufacturer’s instructions on the carton or insert. Keep units segregated by brand, formulation, and expiration date, and rotate stock so shorter-dated inventory is used first when clinically appropriate.

Quick tip: Record the lot number at receiving and again at treatment documentation to support traceability.

For adjunctive supplies, clinics may plan cannulas, needles, antiseptic materials, and aftercare documentation in advance. If your practice uses microinjection accessories for separate skin-quality protocols, the Stylage product tag can help staff locate related line items and education content.

Clinic Workflow and Documentation

Stylage® M Bi-Soft integrates into standard aesthetic workflows that include consultation, photography, consent, skin preparation, product verification, injection, post-care instructions, and follow-up guidance. The 1 mL syringe format supports common session planning, while the included sterile needles help keep the pack ready for procedure setup.

Before treatment, staff should verify the exact product selected, whether lidocaine is present, the expiration date, and the planned treatment area. During documentation, record product name, lot number, injection areas, amount used, technique notes, adverse events if any, and patient instructions provided.

Inventory planning should reflect injector demand, appointment mix, and product differentiation within the Stylage family. Clinics that regularly treat multiple facial zones may stock several gel profiles so injectors can select the most appropriate formulation rather than forcing one filler into every indication.

Authoritative Sources

• American Society of Plastic Surgeons dermal fillers overview
• Laboratoires Vivacy official site

Ready to order? Choose your quantity above, or call 1-800-630-9757 to talk to our customer service team.

This content is for informational purposes only and is not a substitute for professional medical advice.